Publications

List of publications

SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses. Agerer B*, Koblischke M*, Gudipati V*, Montaño-Gutierrez LF, Smyth M, Popa A, Genger JW, Endler L, Florian DM, Mühlgrabner V, Graninger M, Aberle SW, Husa AM, Shaw LE, Lercher A, Gattinger P, Torralba-Gombau R, Trapin D, Penz T, Barreca D, Fae I, Wenda S, Traugott M, Walder G, Pickl WF, Thiel V, Allerberger F, Stockinger H, Puchhammer-Stöckl E, Weninger W, Fischer G, Hoepler W, Pawelka E, Zoufaly A, Valenta R, Bock C, Paster W, Geyeregger R, Farlik M, Halbritter F, Huppa JB**, Aberle JH**, Bergthaler A**. SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses. Science Immunology. 2021 Mar 4;6(57):eabg6461. doi: 10.1126/sciimmunol.abg6461. PMID: 33664060.

Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2. Popa A*, Genger JW*, Nicholson MD, Penz T, Schmid D, Aberle SW, Agerer B, Lercher A, Endler L, Colaço H, Smyth M, Schuster M, Grau ML, Martínez-Jiménez F, Pich O, Borena W, Pawelka E, Keszei Z, Senekowitsch M, Laine J, Aberle JH, Redlberger-Fritz M, Karolyi M, Zoufaly A, Maritschnik S, Borkovec M, Hufnagl P, Nairz M, Weiss G, Wolfinger MT, von Laer D, Superti-Furga G, Lopez-Bigas N, Puchhammer-Stöckl E, Allerberger F, Michor F, Bock C, Bergthaler A. Science Translational Medicine. 2020 Dec 9;12(573):eabe2555. doi: 10.1126/scitranslmed.abe2555. Epub 2020 Nov 23. PMID: 33229462 (Supplementary website with data and scripts)

Dynamics of CD4 T Cell and Antibody Responses in COVID-19 Patients With Different Disease Severity. Koblischke M, Traugott MT, Medits I, Spitzer FS, Zoufaly A, Weseslindtner L, Simonitsch C, Seitz T, Hoepler W, Puchhammer-Stöckl E, Aberle SW, Födinger M, Bergthaler A, Kundi M, Heinz FX, Stiasny K, Aberle JH. Frontiers in Medicine. 2020 Nov 11;7:592629. doi: 10.3389/fmed.2020.592629. eCollection 2020. PMID: 33262993 

Human recombinant soluble ACE2 in severe COVID-19. Zoufaly A, Poglitsch M, Aberle JH, Hoepler W, Seitz T, Traugott M, Grieb A, Pawelka E, Laferl H, Wenisch C, Neuhold S, Haider D, Stiasny K, Bergthaler A, Puchhammer-Stoeckl E, Mirazimi A, Montserrat N, Zhang H, Slutsky AS, Penninger JM. Lancet Respiratory Medicine. 2020 Nov;8(11):1154-1158. doi: 10.1016/S2213-2600(20)30418-5. Epub 2020 Sep 24.PMID: 33131609 

Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020. Alm E, Broberg EK, Connor T, Hodcroft EB, Komissarov AB, Maurer-Stroh S, Melidou A, Neher RA, O’Toole Á, Pereyaslov D; WHO European Region sequencing laboratories and GISAID EpiCoV group. Euro Surveillance. 2020 Aug;25(32):2001410. doi: 10.2807/1560-7917.ES.2020.25.32.2001410.PMID: 32794443 

Severe COVID-19 is associated with elevated serum IgA and antiphospholipid IgA-antibodies. Hasan Ali O, Bomze D, Risch L, Brugger SD, Paprotny M, Weber M, Thiel S, Kern L, Albrich WC, Kohler P, Kahlert CR, Vernazza P, Bühler PK, Schüpbach RA, Gómez-Mejia A, Popa AM, Bergthaler A, Penninger JM, Flatz L. Clinical Infectious Diseases. 2020 Sep 30:ciaa1496. doi: 10.1093/cid/ciaa1496. Online ahead of print.PMID: 32997739 

Emergence of coronavirus disease 2019 (COVID-19) in Austria. Kreidl P, Schmid D, Maritschnik S, Richter L, Borena W, Genger JW, Popa A, Penz T, Bock C, Bergthaler A, Allerberger F. Wiener Klinische Wochenschrift. 2020 Aug 20:1-8. doi: 10.1007/s00508-020-01723-9. PMID: 32816114 

Mutational dynamics and transmission properties of SARS-CoV-2 superspreading events in Austria. Popa A*, Genger JW*, Nicholson M, Penz T, Schmid S, Aberle SW, Agerer B, Lercher A, Endler L, Colaço H, Smyth M, Schuster M, Grau M, Martinez, Pich O, Borena W, Pawelka E, Keszei Z, Senekowitsch M, Laine J, Aberle JH, Redlberger-Fritz M, Karolyi M, Zoufaly A, Maritschnik S, Borkovec M, Hufnagl P, Nairz M, Weiss G, Wolfinger MT, von Laer D, Superti-Furga G, Lopez-Bigas N, Puchhammer-Stöckl E, Allerberger F, Michor F, Bock C, Bergthaler A. 2020 Jul. bioRxiv (https://doi.org/10.1101/2020.07.15.204339)